[ET Net News Agency, 21 March 2023] MEDBOT-B (02252) rose 10.4% to HK$29.2, breaking
above the 250-D SMA of HK$28.926.
It hits an intra-day high of HK$29.2, and an intra-day low of HK$26.5. The total shares
traded was 1.82 million, with a value of HK$51.11m. The active buy/sell ratio is 75:25,
with net buying turnover of HK$25.4m. UBS accounts for greatest net responsive buying
turnover of HK$3.47m, with volume weighted average price of HK$27.981. CHINA INV INFO
accounts for greatest net responsive selling turnover of HK$8.05m, with volume weighted
average price of HK$28.094.
Basic Information
=================
----------------------------------
Nominal 29.200 % Chg +10.40%
High 29.200 Low 26.500
Shares Tr 1.82m Turnover 51.11m
10-D SMA 27.335 %H.V 56.258
20-D SMA 28.173 VWAP 28.091
50-D SMA 30.448 RSI14 51.939
----------------------------------
Status: Breaking above the 250-D SMA, active buy/sell ratio is 75:25, with net buying
turnover of HK$25.4m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
MEDBOT-B (02252) 29.20 +10.40
JACOBIO-B (01167) 9.63 -0.93
EVEREST MED-B (01952) 16.42 -0.96
BRII-B (02137) 5.19 +1.57
KEYMED BIO-B (02162) 62.70 +0.97
NH HEALTH (06606) 32.45 +2.85
AKESO-B (09926) 43.10 +0.12
ALPHAMAB-B (09966) 15.50 +2.51
INNOCARE-B (09969) 8.30 Unchanged
REMEGEN-B (09995) 50.45 +0.90
---------------------------------------------
(ed)